S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Our #1 Laser Stock for May (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
66,000% upside on tiny biotech? (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Our #1 Laser Stock for May (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
66,000% upside on tiny biotech? (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Our #1 Laser Stock for May (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
66,000% upside on tiny biotech? (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
How major US stock indexes fared Friday 6/9/2023
MarketBeat Week in Review – 6/4 - 6/9
Our #1 Laser Stock for May (Ad)
Kevin O'Leary Slams Martha Stewart's Comments on Remote Work: 'Nobody Wants to Work in These Places'
FuelCell Is Back To Realistic Valuation
66,000% upside on tiny biotech? (Ad)
New Mexico reaches $500M settlement with Walgreens in opioid case
With GM and Ford embracing Tesla's EV charging technology, here's what it means for consumers
OTCMKTS:LZAGY

Lonza Group (LZAGY) Stock Forecast, Price & News

$62.40
-1.79 (-2.79%)
(As of 06/9/2023 ET)
Compare
Today's Range
$62.19
▼
$62.71
50-Day Range
$59.80
▼
$65.80
52-Week Range
$43.85
▼
$66.00
Volume
371,214 shs
Average Volume
44,132 shs
Market Capitalization
$46.47 billion
P/E Ratio
N/A
Dividend Yield
0.14%
Price Target
N/A
ProfileAnalyst RatingsChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort Interest

Lonza Group MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.76mentions of Lonza Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
29.34%
From $1.67 to $2.16 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.61 out of 5 stars

See Top Rated MarketRank™ Stocks Here

LZAGY stock logo

About Lonza Group (OTCMKTS:LZAGY) Stock

Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.

Receive LZAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lonza Group and its competitors with MarketBeat's FREE daily newsletter.

LZAGY Stock News Headlines

June 5, 2023 | finance.yahoo.com
Is Lonza Group AG's (VTX:LONN) Recent Performance Tethered To Its Attractive Financial Prospects?
June 4, 2023 | americanbankingnews.com
Lonza Group AG (OTCMKTS:LZAGY) Receives $680.50 Consensus PT from Analysts
June 10, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
May 27, 2023 | americanbankingnews.com
FY2025 Earnings Estimate for Lonza Group AG (OTCMKTS:LZAGY) Issued By KeyCorp
May 24, 2023 | americanbankingnews.com
KeyCorp Weighs in on Lonza Group AG's FY2023 Earnings (OTCMKTS:LZAGY)
May 20, 2023 | americanbankingnews.com
Lonza Group (OTCMKTS:LZAGY) Earns Hold Rating from Analysts at Stifel Nicolaus
May 19, 2023 | finance.yahoo.com
Individual investors account for 56% of Lonza Group AG's (VTX:LONN) ownership, while institutions account for 44%
May 16, 2023 | americanbankingnews.com
Lonza Group AG to Post FY2023 Earnings of $1.76 Per Share, KeyCorp Forecasts (OTCMKTS:LZAGY)
June 10, 2023 | Behind the Markets (Ad)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
May 10, 2023 | americanbankingnews.com
Brokerages Set Lonza Group AG (OTCMKTS:LZAGY) Target Price at $680.50
May 8, 2023 | americanbankingnews.com
Lonza Group AG (OTCMKTS:LZAGY) Announces Dividend Increase - $0.11 Per Share
May 5, 2023 | markets.businessinsider.com
Lonza Announces Results of the 2023 Annual General Meeting All Motions Proposed by Board of Directors Accepted
May 2, 2023 | finance.yahoo.com
Does Lonza Group (VTX:LONN) Deserve A Spot On Your Watchlist?
April 28, 2023 | americanbankingnews.com
Lonza Group AG (OTCMKTS:LZAGY) Short Interest Up 12,600.0% in April
April 22, 2023 | uk.investing.com
Lonza Group AG (LONNE)
April 22, 2023 | msn.com
DAY BY DAY Upgrades Lonza Group (SIX:LONN)
April 20, 2023 | markets.businessinsider.com
Lonza Increases Straight Bond by CHF 150 Million
April 15, 2023 | americanbankingnews.com
Analysts Set Lonza Group AG (OTCMKTS:LZAGY) PT at $680.50
April 11, 2023 | finance.yahoo.com
Lonza Group's (VTX:LONN) five-year earnings growth trails the impressive shareholder returns
March 21, 2023 | americanbankingnews.com
Brokerages Set Lonza Group AG (OTCMKTS:LZAGY) Price Target at $680.50
March 17, 2023 | forbes.com
Lonza Group
February 20, 2023 | investing.com
Citi Reiterates Buy Rating on Lonza Group AG
February 16, 2023 | finance.yahoo.com
The Petri Dish: Blueprint hit with clinical hold, Moderna to set up patient assistance program
January 26, 2023 | finance.yahoo.com
Lonza Group Full Year 2022 Earnings: EPS Beats Expectations
January 25, 2023 | seekingalpha.com
Lonza Group AG (LZAGY) Q4 2022 Earnings Call Transcript
January 25, 2023 | finance.yahoo.com
UPDATE 2-European stocks fall on earnings jitters, rate hike worries
January 25, 2023 | finance.yahoo.com
European stocks fall on earnings jitters, rate hike worries
See More Headlines

LZAGY Price History

LZAGY Company Calendar

Ex-Dividend for 5/26 Dividend
5/09/2023
Dividend Payable
5/26/2023
Today
6/10/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Tobacco products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:LZAGY
CUSIP
N/A
CIK
1446711
Web
www.lonza.com
Phone
(161) 316-8111
Fax
41-61-316-9111
Employees
16,218
Year Founded
1897

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.15
Current Ratio
1.86
Quick Ratio
1.27

Sales & Book Value

Annual Sales
$6.52 billion
Price / Sales
7.13
Cash Flow
$1.40 per share
Price / Cash Flow
44.72
Book Value
$15.01 per share
Price / Book
4.16

Miscellaneous

Outstanding Shares
744,690,000
Free Float
744,167,000
Market Cap
$46.47 billion
Optionable
Not Optionable
Beta
0.97

Social Links


Key Executives

  • Pierre-Alain Ruffieux
    Chief Executive Officer
  • Maria Soler Nunez
    Head-Group Operations
  • Philippe Deecke
    Chief Financial Officer
  • Lyle Wheeler
    Investor Relations Contact
  • Caroline Barth
    Chief Human Resources Officer

Key Competitors

View All Competitors













LZAGY Stock - Frequently Asked Questions

Should I buy or sell Lonza Group stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Lonza Group in the last year. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LZAGY shares.
View LZAGY analyst ratings or view top-rated stocks.

How have LZAGY shares performed in 2023?

Lonza Group's stock was trading at $48.75 on January 1st, 2023. Since then, LZAGY stock has increased by 28.0% and is now trading at $62.40.
View the best growth stocks for 2023 here.

Are investors shorting Lonza Group?

Lonza Group saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 5,200 shares, an increase of 33.3% from the April 30th total of 3,900 shares. Based on an average daily volume of 119,300 shares, the short-interest ratio is currently 0.0 days.
View Lonza Group's Short Interest.

How often does Lonza Group pay dividends? What is the dividend yield for Lonza Group?

Lonza Group declared a dividend on Thursday, May 4th. Stockholders of record on Wednesday, May 10th will be paid a dividend of $0.108 per share on Friday, May 26th. This represents a dividend yield of 0.17%. The ex-dividend date is Tuesday, May 9th. This is an increase from the stock's previous dividend of $0.09.
Read our dividend analysis for LZAGY.

What ETF holds Lonza Group's stock ?

PGIM Jennison Focused Growth ETF holds 7,651 shares of LZAGY stock, representing 1.00% of its portfolio.

Is Lonza Group a good dividend stock?

Lonza Group (OTCMKTS:LZAGY) pays an annual dividend of $0.09 per share and currently has a dividend yield of 0.14%.
Read our dividend analysis for LZAGY.

What is Lonza Group's stock symbol?

Lonza Group trades on the OTCMKTS under the ticker symbol "LZAGY."

How do I buy shares of Lonza Group?

Shares of LZAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lonza Group's stock price today?

One share of LZAGY stock can currently be purchased for approximately $62.40.

How much money does Lonza Group make?

Lonza Group (OTCMKTS:LZAGY) has a market capitalization of $46.47 billion and generates $6.52 billion in revenue each year.

How many employees does Lonza Group have?

The company employs 16,218 workers across the globe.

Does Lonza Group have any subsidiaries?
The following companies are subsidiares of Lonza Group: Arch Acquisition LLC, Arch Chemicals Canada Inc., Arch Chemicals Inc., Arch Chemicals Limited, Arch Chemicals Receivables LLC, Arch Chemicals SAS, Arch Personal Care Products L.P., Arch Protection Chemicals Private Limited, Arch Quimica Argentina S.R.L., Arch Quimica Brasil Ltda., Arch Timber Protection B.V., Arch Treatment Technologies Inc., Arch UK Biocides Limited, Arch Water Products France S.A.S., Arch Water Products South Africa (Pty) Ltd, Arch Wood Protection (Aust) Pty Ltd, Arch Wood Protection (M) Sdn. Bhd., Arch Wood Protection (NZ) Limited, Arch Wood Protection (SA) Pty Ltd, Arch Wood Protection Canada Corp., Arch Wood Protection Inc, Bend Research Inc., BioAtrium AG, CH Capsules Malaysia SDN BHD, Capsugel, Capsugel (Thailand) Co. Ltd, Capsugel Australia Pty Ltd, Capsugel Belgium NV, Capsugel Brasil Importação e Distribuição de Insumos Farmacêuticos e Alimentos Ltda., Capsugel Canada Corp., Capsugel Distribucion S. de R.L. de C.V., Capsugel FinanceCo II S.à r.l., Capsugel FinanceCo S.C.A., Capsugel FinanceCo S.à r.l, Capsugel France Holdings SAS, Capsugel France SAS, Capsugel Funding LLC, Capsugel Germany GmbH, Capsugel Healthcare Private Limited, Capsugel Holdings (Hong Kong) Limited, Capsugel Holdings S.à r.l., Capsugel Holdings US Inc., Capsugel Hungary Kft, Capsugel Inc., Capsugel Italy S.R.L., Capsugel Japan Inc., Capsugel Manufacturing Inc., Capsugel Middle East Sàrl, Capsugel New Zealand Limited, Capsugel Pharmaceutical and Health Products Marketing Ltd, Capsugel Philippines Inc., Capsugel Ploermel SAS, Capsugel S.à r.l., Capsugel Spain S.L., Capsugel US LLC, Capsugel de México S. de R.L. de C.V., Diacon Technologies, Diacon Technologies Limited, Hickson Ltd, InterHealth Nutraceuticals, InterHealth Nutraceuticals Incorporated, LLC Capsugel, Lonza (China) Investments Co. Ltd., Lonza AG, Lonza America Inc., Lonza Argentina S.A, Lonza Biologics Inc., Lonza Biologics Porriño S.L., Lonza Biologics Tuas Pte. Ltd, Lonza Biologics plc, Lonza Bioscience SARL, Lonza Bioscience Singapore Pte Ltd, Lonza Biotec s.r.o., Lonza Cologne GmbH, Lonza Colombia S.A.S, Lonza Copenhagen ApS, Lonza Costa Rica S.A., Lonza Geleen B.V., Lonza Guangzhou Ltd, Lonza Guangzhou Nansha Ltd, Lonza Houston Inc., Lonza Inc., Lonza India Private Limited, Lonza Israel Ltd, Lonza Japan Ltd, Lonza Luxembourg S.à r.l., Lonza Microbial Control Asia Pacific Pte Ltd, Lonza Milano S.r.l., Lonza NZ Limited, Lonza Nanjing Ltd, Lonza Netherlands B.V, Lonza Rockland Inc., Lonza Sales AG, Lonza Shanghai International Trading Ltd, Lonza Suzhou Ltd, Lonza Swiss Finanz AG, Lonza Swiss Licences AG, Lonza Verviers SPRL, Lonza Walkersville Inc., Lonza do Brasil Especialidades Quimicas Ltda., MW Encap (Holdings) Limited, MW Encap Limited, Micro-Macinazione, Micro-Macinazione SA, Octane Biotech, Octane Biotech Inc, P.T. Capsugel Indonesia, PharmaCell, Powdersize LLC, Suzhou Capsugel Limited (JV), Triangle Research Labs, Xcelience Clinical Services Ltd, Xcelience LLC, and Zelam Holdings.
Read More
How can I contact Lonza Group?

Lonza Group's mailing address is Muenchensteinerstrasse 38, Basel V8, 4002. The official website for the company is www.lonza.com. The company can be reached via phone at (161) 316-8111, via email at investor.relations@lonza.com, or via fax at 41-61-316-9111.

This page (OTCMKTS:LZAGY) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -